(0.18%) 5 109.04 points
(0.28%) 38 348 points
(0.24%) 15 966 points
(-1.38%) $82.69
(5.77%) $2.03
(0.13%) $2 350.20
(-0.07%) $27.52
(3.90%) $958.05
(-0.21%) $0.933
(-0.32%) $10.99
(-0.53%) $0.796
(1.67%) $93.41
Live Chart Being Loaded With Signals
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally...
Stats | |
---|---|
本日の出来高 | 1.92M |
平均出来高 | 1.42M |
時価総額 | 55.30B |
EPS | ILA0 ( 2024-01-31 ) |
次の収益日 | ( ILA0.510 ) 2024-05-08 |
Last Dividend | ILA0 ( N/A ) |
Next Dividend | ILA0 ( N/A ) |
P/E | -26.24 |
ATR14 | ILA5.15 (0.10%) |
ボリューム 相関
Teva Pharmaceutical 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Teva Pharmaceutical 相関 - 通貨/商品
Teva Pharmaceutical 財務諸表
Annual | 2023 |
収益: | ILA15.85B |
総利益: | ILA7.65B (48.25 %) |
EPS: | ILA-0.500 |
FY | 2023 |
収益: | ILA15.85B |
総利益: | ILA7.65B (48.25 %) |
EPS: | ILA-0.500 |
FY | 2022 |
収益: | ILA14.93B |
総利益: | ILA6.97B (46.72 %) |
EPS: | ILA-2.12 |
Financial Reports:
No articles found.
Teva Pharmaceutical
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。